NCT03559660No Longer Available不适用
Compassionate Use Program Certolizumab Pegol (CDP-870) in Adults Suffering From Crohn's Disease (CD)
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- No Longer Available
研究概览
简要总结
The objective of this program is to allow treating physicians to supply/continue to supply Certolizumab Pegol (CIMZIA®, CZP) to adults suffering from Crohn's Disease (CD), and who are considered not suitable for treatment, intolerant, have medical contraindications or had insufficient response with an authorized conventional therapy, including other authorized biologics.
研究设计
- 研究类型
- Expanded Access
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient comes from ending open label studies such as WELCOME -C87046, COSPAR - C87065, MUSIC - C87043, PRECISE 3 - C87033, PRECISE 4 - C87034 and C87088
排除标准
- •Patient has been treated with any experimental biological or non biological therapy other than Certolizumab Pegol (CZP) within 5 plasma half-lifes*
- •Has been treated with an approved biological, namely infliximab within the last 8 weeks, and adalimumab within the last 2 weeks*
- •Known hypersensitivity to CZP or any of its excipients
- •Current or recent history of severe, progressive, uncontrolled renal, hepatic, haematological, gastrointestinal (other than Crohn's disease), endocrine, pulmonary, cardiac, neurological, or cerebral disease
- •Serious or life threatening infection within the last 6 months, any signs of current or recent infection
- •Active or latent tuberculosis (TB): if one or more of the 3 criteria is positive for evidence of TB infection*:
- •A medical history of or a recent (< 6 months) active tuberculosis (TB)
- •A recent (<6 months) chest X-ray with signs consistent with TB infection
- •A recent (<6 months) positive purified protein derivative (PPD) skin test (defined as induration or 5mm or more) and/or an indeterminate or positive QuantiFERON-TB Gold or Elispot test.
- •It is recommended that patients are monitored at least annually for active and latent TB by both 1) a chest X-ray read by a pulmonologist or radiologist and 2) a PPD skin test and/or Elispot/ QuantiFERON TB Gold test
- •Patient received live vaccinations including, but not limited to, oral polio, herpes zoster, measles-mumps-rubella (MMR) or nasal influenza within the last 8 weeks or has planned live immunizations during the planned period of administration of CZP
- •Known prior or concurrent viral hepatitis B and C
- •Known Human Immunodeficiency Virus (HIV) infection
- •Concurrent malignancy or a history of malignant disease
- •History of a lymphoproliferative disorder or any signs or symptoms suggestive of this disease
- •History of, or suspected or confirmed active demyelinating disease of the central nervous system
- •History of or concurrent New York Heart Association (NYHA) Class III/IV heart failure
- •As the safety and efficacy of CZP has not been established in patients younger than 18 years of age, drug is not recommended for use in these patients until further data are available
- •As no data are available in pregnant women, drug should not be administered to female patients of childbearing potential - unless an adequate method of contraception is used - or to pregnant/lactating female patients.*
- •'*' Not applicable (NA) for patients on treatment with CZP from trials such as WELCOME -C87046, COSPAR -C87065, MUSIC - C87043, PRECISE 3 - C87033, PRECISE 4 - C87034 and C87088.
研究者
相似试验
No Longer Available
不适用
Named Patient Program With Certolizumab Pegol in Adults Suffering From Rheumatoid Aarthritis (RA)Rheumatoid ArthritisNCT03559686UCB Biopharma SRL
Available
不适用
Linerixibat Compassionate Use for Cholestatic Pruritus Adult Patients With Primary Biliary Cholangitis (PBC)PruritusNCT05448170GlaxoSmithKline
No Longer Available
不适用
Compassionate Use Program With Lacosamide in Patients With Partial-onset or Generalized Tonic-clonic SeizuresEpilepsies, PartialNCT03559673UCB Biopharma S.P.R.L.
Available
不适用
GSK1265744 (Cabotegravir, CAB) for Named Patient/Compassionate Use in HIVInfection, Human Immunodeficiency VirusNCT03462810ViiV Healthcare
No Longer Available
不适用
Compassionate Use Program With Brivaracetam for the Treatment of Patients With EpilepsyEpilepsyNCT03532516UCB Biopharma SRL